Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy

Journal of the American College of Cardiology

Volumn 40, Issue 2, 2002, Pages 271-277

  Dávila Román, Víctor G ^a,b   Vedala, Giridhar ^a   Herrero, Pilar ^a   De Las Fuentes, Lisa ^a   Rogers, Joseph G ^a   Kelly, Daniel P ^a   Gropler, Robert J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

ADAPTATION; ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENERGY METABOLISM; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; MALE; METABOLISM; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; CARBON RADIOISOTOPES; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FATTY ACIDS; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN CONSUMPTION;

EID: 0037125371     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01967-8     Document Type: Article

References (39)

1. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy
2. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance
3. Myocardial phosphocreatinine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy
4. Fatty acid utilization in the hypertrophied and failing heart: Molecular regulatory mechanisms
5. Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism
6. Myosin isozymes redistribution in chronic heart overloading
7. Alterations in gene expression in the rat heart after chronic pathological and physiological loads
8. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat
9. A novel mouse model of lipotoxic cardiomyoparhy
10. Inherited cardiomyopathies
11. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death
12. Arrhythmias and conduction defects as presenting symptoms of fatty acicl oxidation disorders in children
13. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart
14. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
15. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography
16. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate
17. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization
18. Quantitation of myocardial fatty acid metabolism using positron emission tomography
19. Quantification of myocardial glucose utilization by PET and 1-carbon-11-glucose
20. Relationship between carbohydrate metabolism and energy balance of heart muscle
21. Regulation of fatty acid oxidation in the mammalian heart in health and disease
22. Fatty acid oxidation and mechanical performance of volume overloaded rat hearts
23. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts
24. Defective lipid metabolism in the failing heart
25. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure
26. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation
27. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy
28. Total-body and myocardial substrate oxidation in congestive heart failure
29. Free fatty acid kinetics and oxidation in congestive heart failure
30. Myocardial lipid turnover in dilated cardiomyopathy: A dual in vivo tracer approach
31. 18F]fluoro-6-thiaheptadecanoic acid (FTHA): Evaluation in mouse of a new probe of myocardial utilization oflong chain fatty acids
32. 18F]FDG in patients with congestive heart failure
33. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure
34. 123I BMIPP SPECT: Correlation with clinicopathological findings and clinical course
35. External assessment of myocardial metabolism with C-11 palmitate in vivo
36. Differentiation of ischemic from nonischemic cardiomyopathy with positron emission tomography
37. 11C-palmitate
38. Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain Acyl-CoA dehydrogenase deficiency)
39. PPAR signaling in the control of cardiac energy metabolism